Similar articles for PMID: 20846732

Year	Number of Results
2000	1
2001	1
2002	1
2003	1
2004	1
2005	2
2006	5
2007	8
2008	5
2009	7
2010	15
2011	10
2012	12
2013	14
2014	10
2015	11
2016	8
2017	5
2018	5
2019	3
2020	4
2021	9
2022	7
2023	4
2024	0

1

Targeting DNA methylation for epigenetic therapy.

Yang X, Lay F, Han H, Jones PA. Yang X, et al. Trends Pharmacol Sci. 2010 Nov;31(11):536-46. doi: 10.1016/j.tips.2010.08.001. Epub 2010 Sep 16. Trends Pharmacol Sci. 2010. PMID: 20846732 Free PMC article. Review.

2

Will next-generation agents deliver on the promise of epigenetic hypomethylation therapy?

Lowder JN, Taverna P, Issa JP. Lowder JN, et al. Epigenomics. 2015 Oct;7(7):1083-8. doi: 10.2217/epi.15.66. Epub 2015 Nov 6. Epigenomics. 2015. PMID: 26541345 No abstract available.

3

Targeting DNA methylation.

Issa JP, Kantarjian HM. Issa JP, et al. Clin Cancer Res. 2009 Jun 15;15(12):3938-46. doi: 10.1158/1078-0432.CCR-08-2783. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509174 Free PMC article.

4

[Epigenetic therapy in myelodysplastic syndromes (MDS). Treatment with DNA methyltransferase inhibitors].

Daskalakis M, Blagitko-Dorfs N, Hackanson B, Lübbert M. Daskalakis M, et al. Pharm Unserer Zeit. 2010 May;39(3):217-27. doi: 10.1002/pauz.201000369. Pharm Unserer Zeit. 2010. PMID: 20425776 Review. German. No abstract available.

5

Epigenetic drug discovery: targeting DNA methyltransferases.

Foulks JM, Parnell KM, Nix RN, Chau S, Swierczek K, Saunders M, Wright K, Hendrickson TF, Ho KK, McCullar MV, Kanner SB. Foulks JM, et al. J Biomol Screen. 2012 Jan;17(1):2-17. doi: 10.1177/1087057111421212. Epub 2011 Sep 30. J Biomol Screen. 2012. PMID: 21965114 Review.

6

DNA hypermethylation as a chemotherapy target.

Ren J, Singh BN, Huang Q, Li Z, Gao Y, Mishra P, Hwa YL, Li J, Dowdy SC, Jiang SW. Ren J, et al. Cell Signal. 2011 Jul;23(7):1082-93. doi: 10.1016/j.cellsig.2011.02.003. Epub 2011 Feb 21. Cell Signal. 2011. PMID: 21345368 Review.

7

[Epigenetic therapy in myelodysplastic syndromes].

Maki K, Mitani K. Maki K, et al. Rinsho Ketsueki. 2011 Jul;52(7):438-46. Rinsho Ketsueki. 2011. PMID: 21821974 Review. Japanese. No abstract available.

8

Current status of epigenetic treatment in myelodysplastic syndromes.

Kuendgen A, Lübbert M. Kuendgen A, et al. Ann Hematol. 2008 Aug;87(8):601-11. doi: 10.1007/s00277-008-0477-9. Epub 2008 Apr 5. Ann Hematol. 2008. PMID: 18392623 Review.

9

Epigenetic therapies move into new territory, but how exactly do they work?

Tuma RS. Tuma RS. J Natl Cancer Inst. 2009 Oct 7;101(19):1300-1. doi: 10.1093/jnci/djp342. Epub 2009 Sep 15. J Natl Cancer Inst. 2009. PMID: 19755677 No abstract available.

10

[Hypomethylating agents for the treatment of myelodysplastic syndromes].

Itzykson R, Fenaux P. Itzykson R, et al. Bull Cancer. 2011 Aug;98(8):927-34. doi: 10.1684/bdc.2011.1411. Bull Cancer. 2011. PMID: 21821482 Free article. Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year